Nicole Ventura Joins Arteric as Account Executive

Arteric Expands Client Services Team With Seasoned Pharma Veteran. - May 17, 2017 - Arteric

Stelis Biopharma Partners with Merck

Stelis Biopharma, a fully-integrated biopharmaceutical company with capabilities in providing global contract development and manufacturing services, and Merck a premier supplier of solutions and services to the global life science industry, today announced the opening of its Joint Process Scale-Up Lab at the Stelis Biopharma R&D facility in Bengaluru. The lab, which was built as a centre of excellence for bioprocess scale-up and manufacturing services, represents the strength of the two groups. - May 14, 2017 - Stelis Biopharma

MoBiTec to Offer the First Commercially Available Bacillus Subtilis Food Grade Expression System

The Bacillus Food Grade Expression System was created to make the advantages of a Bacillus expression system also accessible to areas where antibiotic resistance gene markers are prohibited (e.g., food and feed industry). - May 11, 2017 - MoBiTec GmbH

US China Innovation and Investment Summit Panel on Biopharmaceuticals to Feature Pulmotect CEO

Molfino, a respiratory medicine specialist, will provide his perspective on balancing the costs of developing and delivering innovative technologies, drug safety and regulatory issues, important learnings to date and the future outlook of therapeutics in modern healthcare. - May 10, 2017 - Pulmotect, Inc

Arteric Technology Utilized in Hypertension Medication Adherence Study at Baylor College of Medicine

Arteric Technology Utilized in Hypertension Medication Adherence Study at Baylor College of Medicine

OnTimeRx® Automated Reminder Service Tested in Stroke Prevention Program Targeting African-American Women. - May 08, 2017 - Arteric

Arteric President and Founder Hans Kaspersetz Featured in Life Science Marketing Podcast

Arteric President and Founder Hans Kaspersetz Featured in Life Science Marketing Podcast

Veteran SEO Speaker and Panelist Discusses Foundational and Leading-Edge SEO Tactics for Life Science and Biotech Marketers - May 08, 2017 - Arteric

Simultaneous Heterologous Gene Expression in Bacillus Megaterium: Vector p3STOP1623-2RBShp

Optimized high performance (hp) vectors for Bacillus megaterium - MoBiTec provides a wide range of useful vectors for the Bacillus megaterium system, including a vector with two ribosome binding sites (2RBS) for simultaneous dual expression. - May 05, 2017 - MoBiTec GmbH

ALPCO to Launch New Zonulin ELISAs and Therapeutic Drug Monitoring Assays for IBD at Digestive Disease Week®

ALPCO to Launch New Zonulin ELISAs and Therapeutic Drug Monitoring Assays for IBD at Digestive Disease Week®

ALPCO will launch new gastrointestinal and inflammatory bowel disease (IBD) assays at Digestive Disease Week® May 7-9, 2017 in Chicago, IL. Included in this launch are two Zonulin ELISAs for the study of gut permeability and celiac disease, as well as therapeutic drug monitoring assays for IBD. - May 02, 2017 - ALPCO

Virun® Strikes a Nerve at Ingredient Marketplace in Orlando, and Launches New, Novel and Highly Informative Website; STATIC 3 Filming Underway

Virun® Strikes a Nerve at Ingredient Marketplace in Orlando, and Launches New, Novel and Highly Informative Website; STATIC 3 Filming Underway

Virun® NutraBiosciences® Gives Probiferrin™ Its’ Coming Out Party and Garners the Attention of Millennial Movers and Shakers; New Virun Website Showcases Innovative Mantra and Formulation Expertise; STATIC 3 Coming Soon to a Mosh-Pit Near You - May 02, 2017 - VIRUN

cliexa's Rheumatoid Arthritis App, cliexa-Ra Scores as the 2nd Best Ra App Out of More Than 700 Tested

cliexa-RA, cliexa™'s rheumatoid arthritis app, has been scored as the 2nd best RA app among 19 best apps selected from 700+ apps to NIH research. - May 02, 2017 - cliexa

AST and ECN Aim to Accelerate the Development of Lignin-Based Products

American Science and Technology to send multiple shipments of organosolv lignin to Energy research Centre of the Netherlands. - April 29, 2017 - American Science and Technology

New Research Identifies Need for Patient-Centric Clinical Trials and Role for CROs

New Research Identifies Patient-centric Strategies for Clinical Development with over 125 Global Research Opinion Leaders. - April 28, 2017 - Life Science Strategy Group, LLC

New Microplate-Based Method to Measure OCR and ECA Under Steady-State [O2]

Cayman Chemical, in collaboration with BMG LABTECH GmbH, has developed a novel assay kit to measure mitochondrial function under a dynamic range of oxygen concentrations. The Mito Stress Test (ACU Format) is designed to measure oxygen consumption rate (OCR) and extracellular acidification (ECA)... - April 26, 2017 - Cayman Chemical Company

Lilu's Garden Announced as Official Sponsor of High Times US Cannabis Cup, SoCal

Lilu's Garden Announced as Official Sponsor of High Times US Cannabis Cup, SoCal

CBD Wholesaler Lilu's Garden Partners with High Times Magazine for Highly Anticipated Southern California Event. - April 21, 2017 - Lilu's Garden

Captozyme Opens Up New Headquarters

After graduating from the University of Florida's Innovation Hub, biotechnology company Captozyme bought their new headquarters in Gainesville, FL. - April 20, 2017 - Captozyme

The NHLBI Grants NuvOx Pharma a 300K Grant to Study the Effects of Their Oxygen Therapeutic on Myocardial Infarction in a Pig Model

The National Heart, Lung, and Blood Institute (NHLBI) has awarded a grant for $317,743 for a study in pigs for NuvOx Pharma's drug, NVX-308, in heart attack. - April 14, 2017 - NuvOx Pharma

Regulatory and Compliance Resources, Inc. Names Vanessa Cousins as Vice President of Corporate Development/Project Operations and General Partner

Jay Jaworski, President of RCR, “I am pleased that Vanessa has moved to invest her time and talents into our company and has become a General Partner in Regulatory and Compliance, Inc. Her extensive experience and proven accomplishments in our industry are highly respected. RCR is privileged... - April 13, 2017 - Regulatory and Compliance Resources, Inc.

Regulatory and Compliance Resources, Inc. Offers Revolutionary New Regulatory Inspection and Audit Management Software Product

Regulatory and Compliance Resources, Inc. has strategically partnered with ComplyWell™ to offer proprietary software management tool CIMS™ (Compliance Inspection Management System) which simplifies the arduous task of managing and documenting a regulatory, internal or third party... - April 13, 2017 - Regulatory and Compliance Resources, Inc.

MiTeGen Opens NANUQ Access Facility

MiTeGen LLC, a provider of innovative consumables and equipment for protein crystallization and single crystal X-ray, announced the opening of the NANUQ Access Facility (NAF) which provides scientists with day-use access to MiTeGen’s revolutionary automated high-speed cryocooling device (NANUQ). - April 12, 2017 - MiTeGen, LLC

Tactiva Therapeutics Reports Data Highlighting a Novel Dual CD4/CD8 T Cell Receptor with Potential for Use Against a Broad Range of Cancers

Tactiva Therapeutics today reported on its unique, dual enhanced adoptive cell therapy (DEACT) platform, incorporating its proprietary, engineered CD4/CD8 T cell receptors (TCR) with potential broad utility in cancer immunotherapy, including melanoma and ovarian cancer. A late breaking abstract... - April 05, 2017 - Tactiva Therapeutics

MoBiTec GmbH to Attend LABVOLUTION/ BIOTECHNICA, May 16-18, 2017, Hannover, Germany

LABVOLUTION with BIOTECHNICA is a fully integrated event that provides a multidisciplinary perspective on all aspects of the laboratory world. Don't miss Northern Europe's leading business platform for laboratory technology and biotechnology. - March 31, 2017 - MoBiTec GmbH

Captozyme Secures $3.4 Million to Continue Enzyme Research

Captozyme, a biotechnology company, recently raised $3.4 million to manufacture and launch their oxalate-degrading enzyme, Nephure, to facilitate those on a low-oxalate diet. - March 27, 2017 - Captozyme

Jivana Biotechnology Inc, is Pleased to Announce the Addition of Dr. Ajay Maker to Its Advisory Committee

Jivana Biotechnology Inc, is Pleased to Announce the Addition of Dr. Ajay Maker to Its Advisory Committee

Dr. Maker brings surgical oncology experience with expertise in liver, gallbladder. colon, pancreatic, and other cancers to Jivana Biotechnology's advisory committee. - March 16, 2017 - Jivana Biotechnology Inc

AdvantaPure(R) Launches AdvantaSil(TM) Brand of Silicone Tubing and Hose

AdvantaPure has rebranded its silicone tubing and reinforced hose under the AdvantaSil name. The products, used primarily for biopharm and pharmaceutical Single-Use processes, have been depended upon by design engineers for years. AdvantaSil products include unreinforced tubing, reinforced hose, pump grade tubing and wire reinforced suction hose. - March 16, 2017 - AdvantaPure

Novel Lipid Research Assay: Lysosomal PLA2 Inhibitor Screen

Inhibition of Lysosomal phospholipase A2 (LPLA2) by a drug candidate can predict its potential to cause drug-induced phospholipidosis, a serious side effect resulting in tissue inflammation and organ damage. - March 11, 2017 - MoBiTec GmbH

MR Solutions Introduces 9.4T Preclinical MRI Imaging Solution to Cardiovascular Sector

MR Solutions’ new 9.4 tesla cryogen free preclinical scanners created great interest from cardiologists at the 20th Annual Scientific Sessions of the Society for Cardiovascular Magnetic Resonance (SCMR). - March 08, 2017 - MR Solutions

MagCore DNA Extraction and Purification Technology Now Available in the US

The MagCore® nucleic acid extraction and purification system is now available through Parallel Devices, a supplier of life science sample preparation products. - March 07, 2017 - Parallel Devices

Regulatory and Compliance Resources, Inc. Opens New Office in the Denver Metro Area

Pharmaceutical, Bio-pharmaceutical drug manufacturing consulting and talent resourcing company expands operations in the growing Denver market. - March 01, 2017 - Regulatory and Compliance Resources, Inc.

Kemwell Announces Successful USFDA Inspection at Bangalore Facility

Kemwell Announces Successful USFDA Inspection at Bangalore Facility

Kemwell Biopharma, a global bio/pharmaceutical contract development and manufacturing company, announced today that its oral solids manufacturing facility located in Bangalore, India has successfully completed a U.S. Food and Drug Administration (USFDA) inspection. The inspection confirmed the... - February 19, 2017 - Kemwell Biopharma Private Limited

Virun® Releases STATIC™ Episode 2 While Under the Influence of Sulfur Hexaflouride, and New Probiotic Technology Makes Wholefoods Take Notice

Virun® Releases STATIC™ Episode 2 While Under the Influence of Sulfur Hexaflouride, and New Probiotic Technology Makes Wholefoods Take Notice

Virun® NutraBiosciences® Ongoing Video Series Explores the Smells of Stability and Voice-changing Gases; Virun’s Patent & Patents-pending Non-refrigerated Shelf-stable Probiotics Become Available to Manufacturers Worldwide - February 14, 2017 - VIRUN

Zifo RnD Solutions Ranked Number 350 Fastest Growing Technology Company on the Deloitte Technology Fast 500™ Asia Pacific 2016

Zifo RnD Solutions today announced that it ranked Number 350 on the Deloitte Technology Fast 500™ Asia Pacific 2016, a ranking of the 500 fastest growing technology companies in Asia Pacific. Rankings are based on percentage revenue growth over three years. Zifo RnD Solutions grew 146 percent... - February 02, 2017 - Zifo RnD Solutions

Bioscience Americas Unveils New, Patient Focused Website

New website allows prospective patients to sign-up for autologous stem cell therapies at the Company's Colombia location. - January 30, 2017 - Bioscience Americas

NuvOx Pharma and Jiangsu Nhwa Pharmaceutical Co., Ltd. Sign Licensing Agreement for Hemorrhagic Shock and Perioperative Blood Loss

NuvOx Pharma LLC and Jiangsu Nhwa Pharmaceutical Co., Ltd. have signed a licensing agreement for the exclusive development and sales of NVX-408 for China for treating hemorrhagic shock and perioperative blood loss. NVX-408 is an oxygen therapeutic that is injected intravenously, flows through the... - January 26, 2017 - NuvOx Pharma

G&L Scientific Inc. Announces Opening of New Offices in Cambridge, Massachusetts

G&L Scientific Inc. Announces Opening of New Offices in Cambridge, Massachusetts

G&L Scientific Inc, the leading provider of clinical and scientific consulting and resource to the healthcare industry (http://www.gandlscientific.com), has announced the opening of new offices in Cambridge, Massachusetts, strengthening and improving access to its expanding team of clinical and scientific consultants and contractors. This is the latest step in G&L’s expansion of its global clinical consulting services throughout the United States. - January 19, 2017 - G&L Scientific Inc

Dr. Shekhar Challa Joins Bioscience Americas Board of Advisors

Dr. Shekhar Challa Joins Bioscience Americas Board of Advisors

Co-Founder of the Kansas Medical Clinic is a renowned gastroenterologist. - January 13, 2017 - Bioscience Americas

The Zoozler Venture Network is Looking for an Idea

You have a fantastic idea for a product or service but you don't know how to go about making it a reality. You know that you'll need investors but how do you get to them? That's where the Zoozler Venture Network can help. The Zoozler Venture Network will take the idea and help make it into a successful reality. - January 13, 2017 - Zoozler

Prefilled Syringes Market to Grow at 3.9% Annually, Predicts Roots Analysis

Roots Analysis has announced the addition of the “Prefilled Syringes Market (4th Edition), 2017-2026” report to its list of offerings. The report provides a comprehensive analysis of the current state and the likely future evolution of the prefilled syringes market. It provides details... - January 08, 2017 - Roots Analysis

Bioscience Americas Names Addition to Its Board of Advisors

Bioscience Americas Names Addition to Its Board of Advisors

Dr. Firas M. Kara joins Board to assist with Bioscience Americas international development efforts. - January 03, 2017 - Bioscience Americas

Immune Response Bio FDA BLA Update HIV Clinicians "Remune Repeatedly Immunogenic"

Immune Response Bio Update HIV Clinicians Verify "Remune Repeatedly Immunogenic" - December 30, 2016 - Immune Response BioPharma, Inc.

3D Map of PC2 to Jump-Start Drug Discovery Efforts in Polycystic Kidney Disease

Scientists from the Structural Genomics Consortium (SGC) and Oxford University report a three-dimensional view of the Polycystin-2 (PC2), a protein that causes autosomal dominant polycystic kidney disease (ADPKD) when mutated, in an article published this week in Nature Structural and Molecular... - December 21, 2016 - The SGC

Thrivous Joins the Tech Inclusion Pledge

Thrivous, a human enhancement company, has joined the Tech Inclusion Pledge as announced by President Obama. At the Global Entrepreneurship Summit this past summer, President Obama announced a commitment by senior leadership from 33 companies of all sizes to fuel American innovation and economic... - December 18, 2016 - Thrivous

Fierce Innovation Awards: Life Sciences Edition Announce Finalists, Innovative Biochips Recognized

Fierce Innovation Awards: Life Sciences Edition Announce Finalists, Innovative Biochips Recognized

Innovative Biochips LLC has been selected as a finalist in Fierce Innovation Awards 2016 for its innovative product, Automated Yeast Aging Analysis System. - December 15, 2016 - Innovative Biochips

Bioscience Americas Lauds Passage of the 21st Century Cures Act

Bioscience Americas Lauds Passage of the 21st Century Cures Act

President Obama is expected to sign this landmark bi-partisan legislation soon. - December 13, 2016 - Bioscience Americas

Stem Cells Can Successfully Treat Patients with Type 1 Diabetes

Stem Cells Can Successfully Treat Patients with Type 1 Diabetes

The Bioscience Americas science team has a 5-year, 76% remission rate treating Type 1 diabetes using a patient's own stem cells. - December 08, 2016 - Bioscience Americas

Life Science Leader and ClinicalLeader.com Announce New Forum for Small to Mid-Sized Pharma and Biotech Companies

Life Science Leader and ClinicalLeader.com are excited to introduce Clinical Leader Forum, a new conference tailored just for executives at pharma and biotech sponsor companies that rely on contract research organizations for clinical trials. The inaugural event is scheduled for May 10 through 11... - December 07, 2016 - Clinical Leader Forum

University of Malaga Researchers Collaborate with AST to Develop New Lignin-Based Products

AST to send multiple shipments of its Organosolv lignin for continued product development efforts. - December 07, 2016 - American Science and Technology

New Research Explores Wearable Technology Utilization in Clinical Trials and the Role of CROs

New Report Identifies Current and Future Wearable Technology Utilization and CRO Implications with 130 Clinical Outsourcing Decision Makers. - December 01, 2016 - Life Science Strategy Group, LLC

Research to be Presented at ASH Annual Meeting Shows Verseon’s New Class of Anticoagulants Prevents Thrombosis While Preserving Platelet Function

Verseon’s anti coagulants are as effective as NOACS at preventing arterial and venous thromboembolism and thrombin-induced pulmonary embolism. Lead candidate has low renal clearance compared to NOACS - highly desirable for patients with impaired renal function. - November 30, 2016 - Verseon

Global Cancer Technology, Inc. Signs Licensing Agreement with the University of California San Diego

Announcing an agreement to purchase patent and IP technology from UCSD for a novel way to track medical instruments using Nano Quantum Dots - November 25, 2016 - Global Cancer Technology, Inc

Zifo RnD Solutions Ranked Number 40 Fastest Growing Technology Company on the Deloitte Technology Fast 50™ India 2016

Attributes its 146% revenue growth to the Zifo team’s collective strength and commitment towards customer’s success. - November 23, 2016 - Zifo RnD Solutions

Press Releases 401 - 450 of 2,967